Tofogliflozin most effective with high baseline insulin
(HealthDay)—The sodium glucose co-transporter 2 inhibitor tofogliflozin is effective for reducing fasting plasma glucose and body weight, particularly in patients with a high insulin level at baseline, according to a study ...
Oct 24, 2017
0
0